Pharmaceutical composition comprising an anticholinergic and a heterocyclic compound
AssigneeBoehringer Ingelheim Pharma GmbH & Co. KG
InventorsChristopher John Montague Meade, Michel Pairet, Michael P. Pieper
Life of this patent
Estimating the term…
Abstract
A method for treating an inflammatory or obstructive disease of the respiratory tract which comprises administering therapeutically effective amounts of both an anticholinergic and a compound of the formula (2) 1 as well as pharmaceutical compositions comprising an anticholinergic and a compound of the formula (2).
Claims23
1) A pharmaceutical composition comprising an anticholinergic and a compound of the formula (2)
- 194
- wherein
- R1 may represent hydrogen, methyl, ethyl, n-butyl, i-butyl, phenyl, 2-ethylphenyl, 2-i-propylphenyl, benzyl, 4-pyridyl, 2-pyridyl, —CO-phenyl, CN or together with R2 may represent a butylene or pentylene bridge;
- R2 may represent hydrogen, methyl, ethyl, or together with R1 may represent a butylene or pentylene bridge, or together with R13 may represent a single bond or a butylene bridge;
- R3 may represent hydrogen;
- R4 may represent methoxy;
- R5 may represent cyclohexyl, phenyl, 3-methoxycarbonylphenyl, 4-methoxycarbonylphenyl, 3-carboxyphenyl, 4-carboxyphenyl, CN, —COOH, —COOMe, —COOEt, 3,5-dichloro-pyridin-4-yl, 4-pyridyl or 4-pyridyl-N-oxide;
- A may represent oxygen or —CH2—;
- B may represent oxygen or one of the groups —C(R12)(R13) or —CH(R15)—CH(R17);
- D may represent a group selected from —CH2—CH2, —CH(Ph)—CH2, —CONH, —CO—CH2, —CH═CH, —C(Ph)═CH, —C(CR18)(CR19)—X, —C(R19a)═Y, —C═C or phenylene;
- R12 may represent hydrogen, methyl, ethyl, i-propyl, phenyl or —CH2—CORx;
- R13 may represent hydrogen or together with R2 may represent a single bond or a butylene bridge;
- R15 may represent hydrogen or together with R17 may represent a single bond;
- R17 may represent hydrogen or
- together with R15 may represent a single bond;
- R18 may represent hydrogen or methyl;
- R19 may represent hydrogen, methoxy, phenyl or CN;
- R19a may represent hydrogen, methyl or phenyl;
- Rx may represent hydroxy, ethoxy, benzyloxy, 2-phenylethyloxy, 4-methylpiperazin-1-yl, 4-phenylpiperazin-1-yl, N-tetrahydroisoquinolinyl, —NH-phenyl, —NH-benzyl, —NH—CH2-(4-methoxyphenyl), —NH—CH2-(4-fluorophenyl), —NH—CH12-(4-chlorophenyl), —NH—CH2-(2-chlorophenyl), —NH-(3-pyridyl), —NH—CH2-(2-pyridyl), —NH—CH2-(3-pyridyl), —NH—CH2-(4-pyridyl), —NH-(3,5-dichloropyridin-4-yl) or —NH-(2-pyrimidinyl);
- X may represent —CH2, —S or —NH—
- Y may represent CH, CCN, CCOOEt or CHCONH,
- or a pharmacologically acceptable acid addition salt thereof, and a pharmaceutically acceptable excipient.
13) A method for treating an inflammatory or obstructive disease of the respiratory tract which comprises administering therapeutically effective amounts of both an anticholinergic and a compound of the formula (2)
- 204
- R1 may represent hydrogen, methyl, ethyl, n-butyl, i-butyl, phenyl, 2-ethylphenyl, 2-i-propylphenyl, benzyl, 4-pyridyl, 2-pyridyl, —CO-phenyl, CN or
- together with R2 may represent a butylene or pentylene bridge;
- R2 may represent hydrogen, methyl, ethyl, or
- together with R1 may represent a butylene or pentylene bridge, or
- together with R13 may represent a single bond or a butylene bridge;
- R3 may represent hydrogen;
- R4 may represent methoxy;
- R5 may represent cyclohexyl, phenyl, 3-methoxycarbonylphenyl, 4-methoxycarbonylphenyl, 3-carboxyphenyl, 4-carboxyphenyl, CN, —COOH, —COOMe, —COOEt, 3,5-dichloro-pyridin-4-yl, 4-pyridyl or 4-pyridyl-N-oxide;
- A may represent oxygen or —CH2—;
- B may represent oxygen or one of the groups —C(R12)(R13) or —CH(R15)—CH(R17);
- D may represent a group selected from —CH2—CH2, —CH(Ph)—CH2, —CONH, —CO—CH2, —CH═CH, —C(Ph)═CH, —C(CR18)(CR19)—X, —C(R19a)═Y, —C═C or phenylene;
- R12 may represent hydrogen, methyl, ethyl, i-propyl, phenyl or —CH2—CORx;
- R13 may represent hydrogen or
- together with R2 may represent a single bond or a butylene bridge;
- R15 may represent hydrogen or
- together with R17 may represent a single bond;
- R17 may represent hydrogen or
- together with R15 may represent a single bond;
- R18 may represent hydrogen or methyl;
- R19 may represent hydrogen, methoxy, phenyl or CN;
- R19a may represent hydrogen, methyl or phenyl;
- Rx may represent hydroxy, ethoxy, benzyloxy, 2-phenylethyloxy, 4-methylpiperazin-1-yl, 4-phenylpiperazin-1-yl, N-tetrahydroisoquinolinyl, —NH-phenyl, —NH-benzyl, —NH—CH2-(4-methoxyphenyl), —NH—CH2-(4-fluorophenyl), —NH—CH2-(4-chlorophenyl), —NH—CH2-(2-chlorophenyl), —NH-(3-pyridyl), —NH—CH2-(2-pyridyl), —NH—CH2-(3-pyridyl), —NH—CH2-(4-pyridyl), —NH-(3,5-dichloropyridin-4-yl) or —NH-(2-pyrimidinyl);
- X may represent —CH2, —S or —NH—
- Y may represent CH, CCN, CCOOEt or CHCONH,
- or a pharmacologically acceptable acid addition salt thereof, and a pharmaceutically acceptable excipient.
Dependencies are inferred from the claim text.